Prestige Consumer Healthcare, Inc. (PBH)
49.92
+0.72
(+1.46%)
USD |
NYSE |
Oct 16, 16:00
49.94
+0.02
(+0.04%)
Pre-Market: 20:00
Prestige Consumer Healthcare Research and Development Expense (Annual)
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| March 31, 2008 | 0.00 |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Supernus Pharmaceuticals, Inc. | 104.13M |
| Phibro Animal Health Corp. | 24.55M |
| Structure Therapeutics, Inc. | 225.85M |
| ANI Pharmaceuticals, Inc. | 51.66M |
| Corcept Therapeutics, Inc. | 254.91M |